More than 10,000 adverse event reports complaining about the side effects of a commonly used drug called Lupron have been filed with the Food and Drug Administration, according to a recent report by ...

ABBOTT PARK, Ill., June 20, 2011 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved a new 45 mg for six-month administration formulation of Lupron ...

Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...

For years, Sharissa Derricott, 30, had no idea why her body seemed to be failing. At 21, a surgeon replaced her deteriorated jaw joint. She’s been diagnosed with degenerative disc disease and ...

Leuprolide acetate for injection is used to treat the symptoms associated with advanced prostate cancer by way of palliative treatment of advanced prostatic cancer. Aurobindo’s subsidiary, Eugia ...

Add Yahoo as a preferred source to see more of our stories on Google. "I filmed a very realistic *post-having-cancer* moment in my life for you guys," explained McKeon in the caption of her recent ...

Dec. 29, 2004 -- The U.S. Food and Drug Administration (FDA) approved in October revisions to safety labeling to advise healthcare professionals of the following changes: leuprolide acetate is ...

Leuprolide acetate 11.25mg; depot susp for IM inj; preservative-free. Leuprolide acetate is a long-acting GnRH analog. A single injection of results in an initial stimulation followed by a prolonged ...